4D-125

N/A

Report date: 2025/07/04 20:00:55

Base Information

Drug Name4D-125
Drug Alias Name4D-125
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV-R100 vector
Mechanisms of ActionRPGR gene transference
TargetsX-linked retinitis pigmentosa GTPase regulator
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator Companies4d Molecular Therapeutics Inc
China Registration ClassN/A

Develop Information

Active Companies4d Molecular Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A